Emerging concepts in metabolically healthy obesity.

Area of Science:

• Cardiovascular Health
• Metabolic Disorders
• Obesity Research

Background:

• Obesity is a primary risk factor for noncommunicable diseases and premature death.
• Metabolically healthy obesity (MHO) is characterized by obesity without common comorbidities.
• The long-term health implications and cardiovascular risk of MHO remain uncertain.

Purpose of the Study:

• To investigate if MHO is truly benign or a transitional phase to unhealthy obesity.
• To explore pathophysiological mechanisms, including hormones and cytokines, contributing to cardiovascular risk in MHO.
• To evaluate subclinical cardiovascular changes in MHO using systemic microcirculation.

Main Methods:

• Review of existing literature on metabolically healthy obesity.
• Analysis of hormonal and cytokine profiles in MHO individuals.
• Assessment of systemic microcirculation to detect subclinical cardiovascular derangement.

Main Results:

• The benign nature of MHO is still debated, with potential for progression to unhealthy obesity.
• Subclinical cardiovascular risk factors may be present in MHO individuals.
• Hormones and cytokines might play a role in MHO-related cardiovascular risk.

Conclusions:

• More research is essential to fully understand MHO pathophysiology.
• Identifying individuals with MHO who are at higher cardiovascular risk is crucial.
• Intensified management strategies may be necessary for certain MHO individuals.